Academic literature on the topic 'Atypical Chemokine Receptors'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Atypical Chemokine Receptors.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Atypical Chemokine Receptors"
Hansell, C. A. H., C. V. Simpson, and R. J. B. Nibbs. "Chemokine sequestration by atypical chemokine receptors." Biochemical Society Transactions 34, no. 6 (October 25, 2006): 1009–13. http://dx.doi.org/10.1042/bst0341009.
Full textBorroni, Elena M., Raffaella Bonecchi, and Annalisa M. VanHook. "Science Signaling Podcast: 30 April 2013." Science Signaling 6, no. 273 (April 30, 2013): pc11. http://dx.doi.org/10.1126/scisignal.2004231.
Full textGroblewska, Magdalena, Ala Litman-Zawadzka, and Barbara Mroczko. "The Role of Selected Chemokines and Their Receptors in the Development of Gliomas." International Journal of Molecular Sciences 21, no. 10 (May 24, 2020): 3704. http://dx.doi.org/10.3390/ijms21103704.
Full textUlvmar, Maria Helena, Elin Hub, and Antal Rot. "Atypical chemokine receptors." Experimental Cell Research 317, no. 5 (March 2011): 556–68. http://dx.doi.org/10.1016/j.yexcr.2011.01.012.
Full textGencer, Selin, Emiel van der Vorst, Maria Aslani, Christian Weber, Yvonne Döring, and Johan Duchene. "Atypical Chemokine Receptors in Cardiovascular Disease." Thrombosis and Haemostasis 119, no. 04 (February 4, 2019): 534–41. http://dx.doi.org/10.1055/s-0038-1676988.
Full textLegler, Daniel F., and Marcus Thelen. "New insights in chemokine signaling." F1000Research 7 (January 23, 2018): 95. http://dx.doi.org/10.12688/f1000research.13130.1.
Full textGustavsson, Martin, Douglas P. Dyer, Chunxia Zhao, and Tracy M. Handel. "Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding." Science Signaling 12, no. 598 (September 10, 2019): eaaw3657. http://dx.doi.org/10.1126/scisignal.aaw3657.
Full textPacheco, Messias Oliveira, Fernanda Agostini Rocha, Thiago Pinheiro Arrais Aloia, and Luciana Cavalheiro Marti. "Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets." Cells 11, no. 24 (December 16, 2022): 4099. http://dx.doi.org/10.3390/cells11244099.
Full textMiyabe, Yoshishige, Chie Miyabe, Vinidhra Mani, Thorsten R. Mempel, and Andrew D. Luster. "Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation." Science Immunology 4, no. 35 (May 10, 2019): eaav5951. http://dx.doi.org/10.1126/sciimmunol.aav5951.
Full textLeick, Marion, Julie Catusse, and Meike Burger. "The Atypical Chemokine Receptor CRAM Mediates CCL19 Transcytosis through Endothelial Cells and Modulates CCL19 Activation of Non-Hodgkin Lymphoma B Cells." Blood 114, no. 22 (November 20, 2009): 2672. http://dx.doi.org/10.1182/blood.v114.22.2672.2672.
Full textDissertations / Theses on the topic "Atypical Chemokine Receptors"
Tiplady, Eleanor Margaret. "Expression and modulation of atypical chemokine receptors on epithelial cells." Thesis, University of Glasgow, 2018. http://theses.gla.ac.uk/30618/.
Full textBenoit, Alice. "Identification du rôle de l’hypoxie dépendante de HIF-1α dans la régulation de l’expression de ACKR2 (Atypical Chemokine Receptor 2) dans le cancer." Electronic Thesis or Diss., Université de Lorraine, 2024. http://www.theses.fr/2024LORR0051.
Full textAnti-cancer therapies, particularly immunotherapy, have made considerable progress in recent years; however, only a small number of patients derive significant and lasting clinical benefit. The incapacity of cytotoxic immune cells to infiltrate the tumor microenvironment explains in part this phenomenon. Immune infiltration depends in particular on the chemokine network, regulated in part by ACKRs. The aim of this thesis was to study the mechanisms involved in the regulation of ACKR2, which regulates the pro inflammatory chemokine network. In silico data showed that both murine and human ACKR2 promoters contain hypoxia response elements. In vitro, hypoxic colorectal, melanoma and breast cancer cells overexpressed ACKR2, which was no longer the case for cells with a deletion of HIF-1α. In vivo, ACKR2 expression was also decreased in HIF-1α-deleted tumors and associated with increased CCL5 and immune infiltration. Chromatin immunoprecipitation showed HIF-1α directly binds onto the HRE motifs of ACKR2 promoter in melanoma cells
Yu, Tian. "Role of atypical chemokine receptor-2 in ocular inflammation." Thesis, University of Aberdeen, 2015. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=229021.
Full textHurson, Catherine Eileen. "Expression and function of the atypical chemokine receptor CCX-CKR." Thesis, University of Glasgow, 2011. http://theses.gla.ac.uk/2718/.
Full textKing, Vicky. "Assessment of the therapeutic potential of the atypical chemokine receptor, D6." Thesis, University of Glasgow, 2010. http://theses.gla.ac.uk/2165/.
Full textTeoh, Pek Joo. "The role of the atypical chemokine receptor D6 in the placenta." Thesis, University of Glasgow, 2014. http://theses.gla.ac.uk/5098/.
Full textLucas, Beth. "Expression and function of the atypical chemokine receptor CCRL1 in the thymus." Thesis, University of Birmingham, 2015. http://etheses.bham.ac.uk//id/eprint/5971/.
Full textVacchini, A. "ANALYSIS OF BIASED SIGNALING IN THE CHEMOKINE SYSTEM." Doctoral thesis, Università degli Studi di Milano, 2016. http://hdl.handle.net/2434/365864.
Full textShams, Kave. "The role and regulation of the atypical chemokine receptor 2 in psoriasiform inflammation." Thesis, University of Glasgow, 2017. http://theses.gla.ac.uk/8121/.
Full textKorniejewska, Anna. "Characterisation of the chemokine receptor CXCR3 and its atypical variants in human T lymphocytes." Thesis, University of Bath, 2009. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.518106.
Full textBooks on the topic "Atypical Chemokine Receptors"
Hughes, Jeremy. Proteinuria as a direct cause of progression. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0137.
Full textBook chapters on the topic "Atypical Chemokine Receptors"
Singh, Mark D., Robert J. B. Nibbs, and Gerard J. Graham. "The Atypical Chemokine Receptors." In Methods and Principles in Medicinal Chemistry, 67–83. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2011. http://dx.doi.org/10.1002/9783527631995.ch4.
Full textBonecchi, Raffaella, Matteo Massara, and Massimo Locati. "Atypical Chemokine Receptors." In Encyclopedia of Immunobiology, 579–85. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-12-374279-7.10009-8.
Full textWerth, Kathrin, and Reinhold Förster. "Active Shaping of Chemokine Gradients by Atypical Chemokine Receptors." In Methods in Enzymology, 293–308. Elsevier, 2016. http://dx.doi.org/10.1016/bs.mie.2015.09.008.
Full textBorroni, Elena, Cinzia Cancellieri, Massimo Locati, and Raffaella Bonecchi. "Dissecting Trafficking and Signaling of Atypical Chemokine Receptors." In Methods in Enzymology, 151–68. Elsevier, 2013. http://dx.doi.org/10.1016/b978-0-12-391862-8.00008-9.
Full textLokeshwar, Bal L., Georgios Kallifatidis, and James J. Hoy. "Atypical chemokine receptors in tumor cell growth and metastasis." In Advances in Cancer Research, 1–27. Elsevier, 2020. http://dx.doi.org/10.1016/bs.acr.2019.12.002.
Full textLuís, Rafael, Giulia D’Uonnolo, Christie B. Palmer, Max Meyrath, Tomasz Uchański, May Wantz, Bernard Rogister, Bassam Janji, Andy Chevigné, and Martyna Szpakowska. "Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors." In Methods in Cell Biology. Elsevier, 2022. http://dx.doi.org/10.1016/bs.mcb.2022.03.002.
Full textSjöberg, Elin, Max Meyrath, Andy Chevigné, Arne Östman, Martin Augsten, and Martyna Szpakowska. "The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy." In Advances in Cancer Research, 99–138. Elsevier, 2020. http://dx.doi.org/10.1016/bs.acr.2019.12.001.
Full textKleist, Andrew B., Francis Peterson, Robert C. Tyler, Martin Gustavsson, Tracy M. Handel, and Brian F. Volkman. "Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3." In Methods in Cell Biology, 259–88. Elsevier, 2019. http://dx.doi.org/10.1016/bs.mcb.2018.09.004.
Full textConference papers on the topic "Atypical Chemokine Receptors"
Jenkins, Brittany D., Rupali Hire, Elizabeth Howerth, Michele Monteil, Rachel Martini, and Melissa B. Davis. "Abstract 953: Atypical chemokine receptor 1 (ACKR1/DARC) expressing tumors are associated with distinct recruitment of immune cells and increased pro-inflammatory chemokines." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-953.
Full textJenkins, Brittany D., Rachel N. Martini, Rupali Hire, Michele A. Monteil, and Melissa B. Davis. "Abstract B39: Distinct recruitment of tumor-associated immune cells correlates with increased pro-malignant chemokines in tumors expressing epithelial Atypical Chemokine Receptor 1 (ACKR1/DARC)." In Abstracts: Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25-28, 2016; Fort Lauderdale, FL. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7755.disp16-b39.
Full textSalazar, Nicole, Daniel Muñoz, and Bal L. Lokeshwar. "Abstract C210: Atypical chemokine receptor 3/CXCR7 and EGFR interact to control breast cancer growth." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-c210.
Full textJenkins, Brittany D., Rachel N. Martini, Inasia Brown, and Melissa B. Davis. "Abstract 5071: The functional relevance of Atypical Chemokine Receptor 1 (ACKR1/DARC) genetic isoforms in breast cancer." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5071.
Full textJenkins, Brittany D., Rachel Martini, Kevin Gardner, Michele Monteil, Dorrah Deeb, Lisa Newman, and Melissa Davis. "Abstract 4565: The functional role of atypical chemokine receptor 1 in immune cell regulation of breast cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4565.
Full textJenkins, Brittany D., Rachel Martini, Kevin Gardner, Michele Monteil, Dorrah Deeb, Lisa Newman, and Melissa Davis. "Abstract 4565: The functional role of atypical chemokine receptor 1 in immune cell regulation of breast cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4565.
Full textKim, Nayoung, Seung-Woo Baek, Hyewon Ryu, Yoon Seok Choi, Ik Chan Song, Hwan Jung Yun, Deog Yeon Jo, Samyong Kim, and Hyo Jin Lee. "Abstract 3947: Atypical chemokine receptor ACKR3 expression is associated with aggressive behavior and poor prognosis in gastric cancer." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3947.
Full textJenkins, BD, RN Martini, R. Hire, MA Monteil, and MB Davis. "Abstract P6-01-11: Distinct recruitment of tumor-associated immune cells correlates with increased pro-malignant chemokines in tumors expressing epithelial atypical chemokine receptor 1 (ACKR1/DARC), indicating a unique tumor microenvironment." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-01-11.
Full text